William Frank Greenlee - Publications

Harvard University, Cambridge, MA, United States 
pharmacology and toxicology

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Hall JM, Barhoover MA, Kazmin D, McDonnell DP, Greenlee WF, Thomas RS. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation. Molecular Endocrinology (Baltimore, Md.). 24: 359-69. PMID 20032195 DOI: 10.1210/edrv.31.1.9999  1
2010 Barhoover MA, Hall JM, Greenlee WF, Thomas RS. Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4. Molecular Pharmacology. 77: 195-201. PMID 19917880 DOI: 10.1124/mol.109.059675  1
1999 Starr TB, Greenlee WF, Neal RA, Poland A, Sutter TR. The trouble with TEFs. Environmental Health Perspectives. 107: A492-3. PMID 10504157  1
1998 Luch A, Coffing SL, Tang YM, Schneider A, Soballa V, Greim H, Jefcoate CR, Seidel A, Greenlee WF, Baird WM, Doehmer J. Stable expression of human cytochrome P450 1B1 in V79 chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene Chemical Research in Toxicology. 11: 686-695. PMID 9625737 DOI: 10.1021/tx970236p  1
1997 Kress S, Greenlee WF. Cell-specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Research. 57: 1264-9. PMID 9102211  1
1996 Tang YM, Wo YYP, Stewart J, Hawkins AL, Griffin CA, Sutter TR, Greenlee WF. Isolation and characterization of the human cytochrome p450 CYP1B1 gene Journal of Biological Chemistry. 271: 28324-28330. PMID 8910454 DOI: 10.1074/jbc.271.45.28324  1
1995 Andersen ME, Mills JJ, Jirtle RL, Greenlee WF. Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology. 102: 223-37. PMID 7482557 DOI: 10.1016/0300-483X(95)03051-G  1
1994 Greenlee WF, Sutter TR, Marcus C. Molecular basis of dioxin actions on rodent and human target tissues Progress in Clinical and Biological Research. 387: 47-57. PMID 7972259  1
1993 Andersen ME, Mills JJ, Gargas ML, Kedderis L, Birnbaum LS, Neubert D, Greenlee WF. Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment. Risk Analysis : An Official Publication of the Society For Risk Analysis. 13: 25-36. PMID 8383868  1
1991 Sutter TR, Guzman K, Dold KM, Greenlee WF. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science (New York, N.Y.). 254: 415-8. PMID 1925598  1
1991 Greenlee WF, Andersen ME, Lucier GW. A perspective on biologically-based approaches to dioxin risk assessment Risk Analysis. 11: 565-568. PMID 1664119 DOI: 10.1111/j.1539-6924.1991.tb00642.x  1
1987 Osborne R, Dold KM, Greenlee WF. Evidence that 2,3,7,8-tetrachlorodibenzo-p-dioxin and thyroid hormones act through different mechanisms in human keratinocytes. Toxicology and Applied Pharmacology. 90: 522-31. PMID 2444020  1
1986 Hudson LG, Toscano WA, Greenlee WF. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) modulates epidermal growth factor (EGF) binding to basal cells from a human keratinocyte cell line. Toxicology and Applied Pharmacology. 82: 481-92. PMID 3952731  1
1985 Greenlee WF, Osborne R, Dold KM, Hudson LG, Toscano WA. Toxicity of chlorinated aromatic compounds in animals and humans: in vitro approaches to toxic mechanisms and risk assessment. Environmental Health Perspectives. 60: 69-76. PMID 2992929  1
1985 Hudson LG, Toscano WA, Greenlee WF. Regulation of epidermal growth factor binding in a human keratinocyte cell line by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology. 77: 251-9. PMID 2579474  1
1983 Hudson LG, Shaikh R, Toscano WA, Greenlee WF. Induction of 7-ethoxycoumarin o-deethylase activity in cultured human epithelial cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): evidence for TCDD receptor. Biochemical and Biophysical Research Communications. 115: 611-7. PMID 6312985  1
1979 Greenlee WF, Poland A. Nuclear uptake of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice; Role of the hepatic cytosol receptor protein Journal of Biological Chemistry. 254: 9814-9821. PMID 489572  1
1979 Poland A, Greenlee WF, Kende AS. Studies on the mechanism of action of the chlorinated dibenzo-p-dioxins and related compounds. Annals of the New York Academy of Sciences. 320: 214-30. PMID 110192  1
1978 Greenlee WF, Poland A. An improved assay of 7-ethoxycoumarin O-deethylase activity: Induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin Journal of Pharmacology and Experimental Therapeutics. 205: 596-605. PMID 660532  1
Show low-probability matches.